Mark Mallon
Chief Executive Officer bij NeoGenomics Laboratories, Inc.
Profiel
De heer Mark Mallon is Chief Executive Officer & Bestuurder bij NeoGenomics Laboratories, Inc. en Chief Executive Officer & Bestuurder bij NeoGenomics, Inc. Hij zetelt in de Raad van Bestuur van NeoGenomics Laboratories, Inc. en NeoGenomics, Inc. De heer Mallon was voordien werkzaam als Chief Executive Officer & Director bij Ironwood Pharmaceuticals, Inc., President bij Astrazeneca China Ltd., Chief Operating Officer bij Astrazeneca Japan Ltd., Vice-President Marketing & Sales Operations bij AstraZeneca Pharmaceuticals LP, en Executive Vice-President-International bij AstraZeneca Plc. Hij was ook lid van de raad van bestuur van Christiana Care Corp. Hij behaalde zijn doctorale graad aan de Universiteit van Pennsylvania en een MBA aan The Wharton School van de Universiteit van Pennsylvania.
Actieve functies van Mark Mallon
| Bedrijven | Functie | Begin |
|---|---|---|
NeoGenomics Laboratories, Inc.
 NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Chief Executive Officer | 19-04-2021 |
Eerdere bekende functies van Mark Mallon
| Bedrijven | Functie | Einde |
|---|---|---|
| NEOGENOMICS, INC. | Chief Executive Officer | 28-03-2022 |
| IRONWOOD PHARMACEUTICALS, INC. | Chief Executive Officer | 12-03-2021 |
| Astrazeneca China Ltd. | President | 01-11-2011 |
Astrazeneca Japan Ltd.
 Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The private company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram. | Chief Operating Officer | 01-04-2011 |
AstraZeneca SpA
 AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | President | - |
Opleiding van Mark Mallon
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| NEOGENOMICS, INC. | Health Services |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | Health Technology |
Astrazeneca Japan Ltd.
Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The private company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram. | Health Services |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Health Services |
| Astrazeneca China Ltd. | |
Christiana Care Corp.
 Christiana Care Corp. Hospital/Nursing ManagementHealth Services Christiana Care Corp. operates as a healthcare organization. The private company is based in Middletown, DE. | Health Services |
